B Braun Medical Company Profile
What is the competitive landscape for B BRAUN MEDICAL
B BRAUN MEDICAL has sixteen approved drugs.
There are three US patents protecting B BRAUN MEDICAL drugs.
Summary for B Braun Medical
| US Patents: | 3 |
| Tradenames: | 16 |
| Ingredients: | 15 |
| NDAs: | 16 |
Drugs and US Patents for B Braun Medical
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| B Braun Medical | ACETAMINOPHEN | acetaminophen | SOLUTION;INTRAVENOUS | 204957-002 | Feb 18, 2021 | AP2 | RX | Yes | Yes | ⤷ Start Trial | ⤷ Start Trial | ||||
| B Braun Medical | MAGNESIUM SULFATE IN DEXTROSE 5% IN PLASTIC CONTAINER | magnesium sulfate | INJECTABLE;INJECTION | 207966-001 | Oct 27, 2020 | AP | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ||||
| B Braun Medical | TROMETHAMINE | tromethamine | SOLUTION;INJECTION | 211558-001 | Dec 9, 2024 | AP | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for B Braun Medical
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
|---|---|---|---|---|---|---|---|
| B Braun Medical | CLOROTEKAL | chloroprocaine hydrochloride | SOLUTION;INTRATHECAL | 208791-001 | Sep 26, 2017 | 8,969,412 | ⤷ Start Trial |
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for B Braun Medical Drugs
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| South Korea | 20150085131 | ⤷ Start Trial |
| Taiwan | 201412317 | ⤷ Start Trial |
| Mexico | 2015004056 | ⤷ Start Trial |
| >Country | >Patent Number | >Estimated Expiration |
Supplementary Protection Certificates for B Braun Medical Drugs
| Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
|---|---|---|---|---|
| 2957286 | 132019000000021 | Italy | ⤷ Start Trial | PRODUCT NAME: PATIROMER SORBITEX CALCIUM E QUALSIASI SUO SALE O DERIVATO(VELTASSA); AUTHORISATION NUMBER(S) AND DATE(S): EU/1/17/1179, 20170721 |
| 0984957 | CR 2012 00035 | Denmark | ⤷ Start Trial | PRODUCT NAME: ET KOMBINATIONSPRODUKT AF NAPROXEN OG ESOMEPRAZOL MAGNESIUM TRIHYDRAT; NAT. REG. NO/DATE: 49583 20120327; FIRST REG. NO/DATE: GB PL 17901/0263-001 20101105 |
| 1259550 | CA 2009 00002 | Denmark | ⤷ Start Trial | PRODUCT NAME: SUGAMMADEX ELLER FARMACEUTISK AKTIVE SALTE ELLER ESTERE DERAF, HERUNDER SUGAMMADEXNATRIUM |
| >Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
